USPTO serial 77220721
CYCLOPRET
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 19, 2009
- Examiner
- CAPSHAW, DANIEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with CYCLOPRET?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
92318 - Neumarkt, DE
92318 - Neumarkt, DE
92318 - Neumarkt, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kenneth F. Florek
Kenneth F. Florek FLOREK & ENDRES PLLC1156 Avenue of the AmericasSuite 600New York, NY 10036-2702Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations for the treatment of gynecological disorders, namely, gynecological disorders affecting menstruation, menstrual irregularities, polycystic ovarian syndrome, uterine bleeding, endometriosis and psychic complaints, nervousness, depression, mood disorders, mood changes, anxiety disorders, affective and cognitive disorders, hot flashes, perspiration, weeping spasm, headache, vertigo, palpitation, insomnia, premenstrual syndrome, menstrual disorders, mastodynia, mastalgia, mastopathy, gastrointestinal disorders, bone and joint pains, backache, breast pain, dizziness, headache, nausea, vomiting, diarrhea, tenseness, sexual dysfunction, acne, rashes, hirsutism, obesity, fertility disorders, hyperprolactinemia; pharmaceutical and veterinary preparations, namely, plant extracts for the treatment of gynecological disorders, namely, gynecological disorders affecting menstruation, menstrual irregularities, polycystic ovarian syndrome, uterine bleeding, endometriosis and psychic complaints, nervousness, depression, mood disorders, mood changes, anxiety disorders, affective and cognitive disorders, hot flashes, perspiration, weeping spasm, headache, vertigo, palpitation, insomnia, premenstrual syndrome, menstrual disorders, mastodynia, mastalgia, mastopathy, gastrointestinal disorders, bone and joint pains, backache, breast pain, dizziness, headache, nausea, vomiting, diarrhea, tenseness, sexual dysfunction, acne, rashes, hirsutism, obesity, fertility disorders, hyperprolactinemia; gynecologic oriental medicine for the treatment of gynecological disorders, namely, gynecological disorders affecting menstruation, menstrual irregularities, polycystic ovarian syndrome, uterine bleeding, endometriosis and psychic complaints, nervousness, depression, mood disorders, mood changes, anxiety disorders, affective and cognitive disorders, hot flashes, perspiration, weeping spasm, headache, vertigo, palpitation, insomnia, premenstrual syndrome, menstrual disorders, mastodynia, mastalgia, mastopathy, gastrointestinal disorders, bone and joint pains, backache, breast pain, dizziness, headache, nausea, vomiting, diarrhea, tenseness, sexual dysfunction, acne, rashes, hirsutism, obesity, fertility disorders, hyperprolactinemia; dietary supplements in the form of tablets, drops, capsules, extract preparations, balms and/or in liquid form, containing plant extracts for the treatment of gynecological disorders, namely, gynecological disorders affecting menstruation, menstrual irregularities, polycystic ovarian syndrome, uterine bleeding, endometriosis and psychic complaints, nervousness, depression, mood disorders, mood changes, anxiety disorders, affective and cognitive disorders, hot flashes, perspiration, weeping spasm, headache, vertigo, palpitation, insomnia, premenstrual syndrome, menstrual disorders, mastodynia, mastalgia, mastopathy, gastrointestinal disorders, bone and joint pains, backache, breast pain, dizziness, headache, nausea, vomiting, diarrhea, tenseness, sexual dysfunction, acne, rashes, hirsutism, obesity, fertility disorders, hyperprolactinemia; food supplements, dietary food supplements and/or herbal supplements in the form of tablets, drops, capsules, extract preparations, balms and/or in liquid form, containing plant extracts for the treatment of gynecological disorders, namely, gynecological disorders affecting menstruation, menstrual irregularities, polycystic ovarian syndrome, uterine bleeding, endometriosis and psychic complaints, nervousness, depression, mood disorders, mood changes, anxiety disorders, affective and cognitive disorders, hot flashes, perspiration, weeping spasm, headache, vertigo, palpitation, insomnia, premenstrual syndrome, menstrual disorders, mastodynia, mastalgia, mastopathy, gastrointestinal disorders, bone and joint pains, backache, breast pain, dizziness, headache, nausea, vomiting, diarrhea, tenseness, sexual dysfunction, acne, rashes, hirsutism, obesity, fertility disorders, hyperprolactinemia | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 25, 2015 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Apr 27, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 19, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 13, 2009 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Apr 11, 2009 | ALIE | ASSIGNED TO LIE | — |
| Apr 9, 2009 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 16, 2009 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 16, 2009 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 26, 2009 | IUAF | USE AMENDMENT FILED | — |
| Feb 26, 2009 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Aug 19, 2008 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 19, 2008 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 19, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 4, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 11, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 21, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 3, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 3, 2007 | ALIE | ASSIGNED TO LIE | — |
| Oct 1, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 25, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 5, 2007 | NWAP | NEW APPLICATION ENTERED | — |